Pii has established a global reach through its locations in the US and Europe
Join our Mailing List
Pii has over 430,000 sq. feet of product development laboratory and cGMP manufacturing space. From prototype development to commercial launch, Pii's quality designed facilities are integrated to ensure development milestones are met on time and on budget.
Headquartered in Hunt Valley, Maryland, Pii’s facilities are custom designed and include formulation, analytical laboratories, and cGMP manufacturing suites. With our broad range of experience and deep expertise, we have the talent and technologies to help bring your drug candidate from idea to market. This is backed by over 430,000 square feet of development and manufacturing space, with facilities located in the US and Europe.
Pii’s state-of-the-art facilities consist of over 70 production rooms, including manufacturing and containment suites, dedicated soft gel suites, a formulation development center, and analytical laboratories as well as a development and manufacturing site in the UK. Facilities have been inspected by the FDA and EMA and are registered with the DEA for Schedules I-V. In the UK, Pii has over 45,000 square feet of MHRA-approved cGMP facility space dedicated to Phase I and II manufacturing; solid state screening and oral and inhaled drug delivery development.